| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.525 | 8.574 | 7.433 | 7.042 | 8.117 | 14.922 | 19.054 | 21.506 | 21.867 | 19.770 |
| Total Income - EUR | 7.525 | 8.574 | 7.433 | 7.042 | 8.117 | 15.456 | 19.054 | 21.506 | 21.867 | 19.770 |
| Total Expenses - EUR | 10.168 | 9.745 | 8.046 | 7.163 | 6.158 | 10.110 | 10.202 | 13.911 | 18.577 | 13.366 |
| Gross Profit/Loss - EUR | -2.643 | -1.170 | -613 | -121 | 1.959 | 5.347 | 8.852 | 7.595 | 3.290 | 6.404 |
| Net Profit/Loss - EUR | -2.872 | -1.342 | -688 | -333 | 1.775 | 5.204 | 8.661 | 7.413 | 3.101 | 6.206 |
| Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Zvl Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.934 | 1.591 | 1.246 | 911 | 587 | 275 | 928 | 528 | 125 | 625 |
| Current Assets | 2.140 | 2.571 | 2.749 | 2.794 | 4.856 | 4.660 | 15.478 | 18.831 | 13.491 | 14.861 |
| Inventories | 93 | 92 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 581 | 1.179 | 836 | 987 | 3.078 | 1.244 | 2.145 | 2.698 | 3.630 | 3.825 |
| Cash | 1.465 | 1.299 | 1.913 | 1.807 | 1.778 | 3.415 | 13.333 | 16.133 | 9.861 | 11.036 |
| Shareholders Funds | -1.146 | -2.476 | -2.641 | -2.925 | -1.093 | 4.132 | 12.701 | 13.826 | 10.996 | 14.125 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.220 | 6.638 | 6.635 | 6.630 | 6.536 | 803 | 3.705 | 5.533 | 2.619 | 1.361 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Zvl Medica Srl